Skip to content
Screener

Veradermics MANE Prepaid & Other Current

Prepaid & Other Current at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$4.83B+10.7%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$80.49M+16.4%
Organon logo
OrganonOGN
$1.06B+5.4%
PVL
Palvella TherapeuticsPVLA
$1.38M-24.9%
TTR
Turn Therapeutics Inc.TTRX
$235.17K-18.1%
PTH
Pelthos TherapeuticsPTHS
$2.46M+14,939%

Other financials

Income statement

See full
Operating income-$29.9M-131%
Net income-$27.2M-120%
EPS (diluted)-$1.32+93.3%

Balance sheet

See full
Cash & equivalents$168.4M+419%
Total debt$4.0K
Total equity$390.6M+744%
Total assets$397.4M

Cash flow

See full
Operating cash flow-$21.2M-59.0%
CapEx--100%
Free cash flow-$21.2M-58.7%

Valuation

See full
Market cap$4.78B+280%

Returns & leverage

See full
Return on equity-28.7%
Current ratio59.1×

Where this comes from

Reported directly by Veradermics in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Veradermics’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 5:06 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001827635-26-000019

FAQ

What is Veradermics's prepaid & other current?
Veradermics (MANE) reported prepaid & other current of $6.27M in Q1 2026.
How has Veradermics's prepaid & other current changed year-over-year?
Veradermics's prepaid & other current increased by 8039.2% year-over-year, from -$79K to $6.27M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Veradermics's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude